DBT in Borderline Personality Disorder
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00252031 |
Recruitment Status : Unknown
Verified November 2005 by Bronx VA Medical Center.
Recruitment status was: Recruiting
First Posted : November 11, 2005
Last Update Posted : November 21, 2005
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Borderline Personality Disorder | Behavioral: Dialectical Behavioral Therapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Dialectical Behavioral Therapy for Patients With Borderline Personality Disorder |

- Measures of parasuicidal behavior, suicidal ideation, mood and emotion, dissociation and health care utilization at baseline, 3 months, 6 months and 9 months
- Measures of cognitive processing at baseline and 6 months

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria: Is a male or female between 18 and 60 who meets criteria for Borderline Personality Disorder and has had at least 2 prior instances of suicidal or parasuicidal behavior. Either is off psychotropic drugs or is on a stable medication regimen. (During the study, psychotropic medications will be prescribed by a psychiatrist in the Mood and Personality Disorders Group.)
Exclusion Criteria: Meets criteria for Schizophrenia, Bipolar Disorder, Mental Retardation or current or recent Substance Dependence. Subjects also should not currently be in individual psychotherapy. (Case management and work therapy programs are allowed.)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00252031
Contact: Emily Hart | 212-241-0441 | mpgroup@mssm.edu |
United States, New York | |
Bronx VA Medical Center | Recruiting |
Bronx, New York, United States, 10468 |
Principal Investigator: | Marianne Goodman, MD | Bronx VA Medical Center/Mount Sinai School of Medicine |
ClinicalTrials.gov Identifier: | NCT00252031 |
Other Study ID Numbers: |
3277-02-0002 |
First Posted: | November 11, 2005 Key Record Dates |
Last Update Posted: | November 21, 2005 |
Last Verified: | November 2005 |
Borderline Personality Disorder BPD Dialectical Behavior Therapy DBT |
Disease Personality Disorders Borderline Personality Disorder Pathologic Processes Mental Disorders |